General Information of the Protein
Protein ID
PT02997
Protein Name
Isocitrate dehydrogenase [NADP] cytoplasmic
Secondarily
Protein Name
Cytosolic NADP-isocitrate dehydrogenase
IDPc
NADP(+)-specific ICDH
Oxalosuccinate decarboxylase
Gene Name
IDH1
Secondarily
Gene Name
PICD
Sequence
MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Oxidoreductase
Function
Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase (PubMed:10521434, PubMed:19935646). Plays a critical role in the generation of NADPH, an important cofactor in many biosynthesis pathways (PubMed:10521434). May act as a corneal epithelial crystallin and may be involved in maintaining corneal epithelial transparency (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
O75874

Secondarily ID:
Q567U4
Q6FHQ6
Q7Z3V0
Q93090
Q9NTJ9
Q9UKW8
    Show/Hide
Ensembl ID
ENSG00000138413
HGNC ID
HGNC:5382
Subcellular Location
Cytoplasm
Cytosol
Peroxisome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000539 , COR-L105
Compound ID Compound Name Compound Formula
CP0096015
(2S)-2-(2-chlorophenyl)-2-[[2-[(2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]-(5-fluoropyridin-3-yl)amino]-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C29H24ClF3N6O3
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0076794
US10028961, Compound 101
   Show/Hide
C14H13ClF6N6
 1
1 IC50 = 0.04 nM
CP0096015
(2S)-2-(2-chlorophenyl)-2-[[2-[(2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]-(5-fluoropyridin-3-yl)amino]-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C29H24ClF3N6O3
 7
1 IC50 = 3 nM
2 IC50 = 5 nM
3 IC50 = 8 nM
4 IC50 = 12 nM
5 IC50 = 13 nM
6 IC50 = 24 nM
7 IC50 = 71 nM
CP0720560
(R)-1-(4-fluorobenzyl)-N-(3-((S)-1-hydroxyethyl)phenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide
   Show/Hide
C28H28FN5O3
 4
1 IC50 = 3.8 nM
2 IC50 = 4.6 nM
3 IC50 = 15 nM
4 IC50 = 17 nM
CP0465228
(4S)-3-[2-[[(1S)-1-[5-(2-tert-butylpyridin-4-yl)pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C26H32N6O2
 1
1 IC50 = 4 nM
CP0076796
5-[[(1S)-1-[6-chloro-2-oxo-7-[(1R)-1-pyridin-2-ylethoxy]-1H-quinolin-3-yl]ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
   Show/Hide
C25H22ClN5O3
 3
1 IC50 = 4 nM
2 IC50 = 8 nM
3 IC50 < 10 nM
CP0762758
(S)-2-(1-(6-chloro-7-isopropoxy-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C20H20ClN5O3
 2
1 IC50 = 4 nM
2 IC50 = 26 nM
CP0355999
(4S)-N-[(1S)-7-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-3-(4-cyanopyrimidin-2-yl)-N-(3-fluorophenyl)-2-oxo-1,3-oxazolidine-4-carboxamide
   Show/Hide
C29H22ClF3N6O4
 1
1 IC50 = 5.6 nM
CP0196436
US10112931, Example 388
   Show/Hide
C20H20ClFN6O2
 1
1 IC50 = 6 nM
CP0368867
(2S)-2-(2-chlorophenyl)-2-(N-[2-[(2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]-3,5-difluoroanilino)-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C30H24ClF4N5O3
 1
1 IC50 = 6 nM
CP0179106
(2S)-2-(2-chlorophenyl)-2-(N-[2-[(2S,4S)-1-(4-cyanopyrimidin-2-yl)-4-hydroxy-5-oxopyrrolidin-2-yl]acetyl]-3,5-difluoroanilino)-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C29H23ClF4N6O4
 1
1 IC50 = 7 nM
CP0188595
5-[[(1S)-1-[6-chloro-7-(cyclopropylmethoxy)-2-oxo-1H-quinolin-3-yl]ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
   Show/Hide
C22H21ClN4O3
 3
1 IC50 = 8 nM
2 IC50 < 10 nM
3 IC50 = 24 nM
CP0315105
(2S)-2-(2-chlorophenyl)-2-(N-[2-[(2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]-3-fluoroanilino)-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C30H25ClF3N5O3
 1
1 IC50 = 9 nM
CP0669565
(S)-2-(1-(6-chloro-7-methoxy-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C18H16ClN5O3
 3
1 IC50 = 9 nM
2 IC50 < 10 nM
3 IC50 = 36 nM
CP0714072
(S)-2-(1-(6-chloro-7-cyclopropyl-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C20H18ClN5O2
 2
1 IC50 = 9 nM
2 IC50 = 305 nM
CP0096013
(2S)-2-(2-chlorophenyl)-2-(N-[2-[(2S,4S)-1-(4-cyanopyridin-2-yl)-4-hydroxy-5-oxopyrrolidin-2-yl]acetyl]-3,5-difluoroanilino)-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C30H24ClF4N5O4
 1
1 IC50 = 10 nM
CP0179575
5-[[(1S)-1-[6-chloro-2-oxo-7-(pyridin-2-ylmethoxy)-1H-quinolin-3-yl]ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
   Show/Hide
C24H20ClN5O3
 2
1 IC50 < 10 nM
2 IC50 = 11 nM
CP0660547
(S)-4-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-2-methoxybenzonitrile
   Show/Hide
C19H16ClN3O2
 3
1 IC50 < 10 nM
2 IC50 = 14 nM
3 IC50 = 111 nM
CP0107120
US10112931, Example 466
   Show/Hide
C23H22F4N6O2
 5
1 IC50 = 11 nM
2 IC50 = 18 nM
3 IC50 = 27 nM
4 IC50 = 28 nM
5 IC50 = 6140 nM
CP0202839
(2S)-2-(2-chlorophenyl)-2-(N-[2-[(2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]-3-fluoro-5-sulfamoylanilino)-N-(3,3-difluorocyclobutyl)acetamide
   Show/Hide
C30H26ClF3N6O5S
 1
1 IC50 = 11 nM
CP0326564
5-[[(1S)-1-(6-chloro-7-methoxy-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
   Show/Hide
C19H17ClN4O3
 2
1 IC50 = 11 nM
2 IC50 = 40 nM
CP0745638
(S)-2-(1-(6-chloro-7-(cyclopropylmethoxy)-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C21H20ClN5O3
 2
1 IC50 = 11 nM
2 IC50 = 53 nM
CP0217390
(4S)-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C24H25F3N6O2
 1
1 IC50 = 13 nM
CP0465227
(4S)-3-[2-[[(1S)-1-[6-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C24H25F3N6O2
 1
1 IC50 = 15 nM
CP0660534
(S)-6-((1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-4-methoxynicotinonitrile
   Show/Hide
C18H15ClN4O2
 2
1 IC50 = 17 nM
2 IC50 = 178 nM
CP0839866
(S)-2-(1-(6-chloro-2-oxo-7-(pyridin-2-ylmethoxy)-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C23H19ClN6O3
 2
1 IC50 = 17 nM
2 IC50 = 43 nM
CP0714073
(S)-2-((1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C17H14ClN5O2
 4
1 IC50 = 18 nM
2 IC50 = 81.4 nM
3 IC50 = 130 nM
4 IC50 = 35000 nM
CP0267135
US10640534, Compound 176
   Show/Hide
C28H22ClF3N6O3
 3
1 IC50 = 19 nM
2 IC50 = 63 nM
3 IC50 = 65 nM
CP0240938
(4S)-3-[2-[[(1S)-1-[5-(4-fluoro-3-methylphenyl)pyrimidin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C23H25FN6O2
 1
1 IC50 = 20 nM
CP0750884
(S)-6-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-2-methylnicotinonitrile
   Show/Hide
C18H15ClN4O
 2
1 IC50 = 20 nM
2 IC50 = 183 nM
CP0315190
(4R)-4-(fluoromethyl)-3-[2-[[(1S)-1-[1-[4-(trifluoromethyl)phenyl]imidazol-4-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C20H18F4N6O2
 3
1 IC50 = 21 nM
2 IC50 = 45 nM
3 IC50 = 2520 nM
CP0117201
Ft-2102
   Show/Hide
C18H15ClN4O2
 3
1 IC50 = 21.2 nM
2 IC50 = 114 nM
3 IC50 = 22400 nM
CP0233817
(2S)-N-[(1S)-7-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-1-(4-cyanopyrimidin-2-yl)-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C30H24ClF3N6O3
 1
1 IC50 = 22 nM
CP0239174
(2S)-1-(4-cyanopyrimidin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3,5-difluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C30H24F4N6O3
 1
1 IC50 = 22 nM
CP0762754
(S)-6-((1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-2-methoxynicotinonitrile
   Show/Hide
C18H15ClN4O2
 2
1 IC50 = 24 nM
2 IC50 = 190 nM
CP0147089
5-[[(1S)-1-(6-chloro-7-fluoro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
   Show/Hide
C18H14ClFN4O2
 2
1 IC50 = 25 nM
2 IC50 = 159 nM
CP0306593
(4R)-3-[2-[[1-[1-(3-chloro-4-fluorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H19ClF2N6O2
 1
1 IC50 = 25 nM
CP0220583
(4R)-3-[2-[[1-[1-(3-chloro-5-fluorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H19ClF2N6O2
 1
1 IC50 = 27 nM
CP0393056
(4R)-4-(fluoromethyl)-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C22H20F4N6O2
 1
1 IC50 = 28 nM
CP0164416
(4R)-3-[6-chloro-2-[[1-[1-(3-chloro-4-fluorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H18Cl2F2N6O2
 1
1 IC50 = 32 nM
CP0509652
(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[1-[1-[3-(trifluoromethyl)phenyl]imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C22H20F4N6O2
 1
1 IC50 = 32 nM
CP0412482
US10112931, Example 59
   Show/Hide
C23H23F3N6O3
 1
1 IC50 = 33 nM
CP0239715
(2S)-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-2-(3-fluoro-N-[2-[(2S)-1-pyrimidin-2-ylpyrrolidin-2-yl]acetyl]anilino)acetamide
   Show/Hide
C28H27ClF3N5O2
 1
1 IC50 = 34 nM
CP0080002
(4S)-4-ethyl-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C23H23F3N6O2
 1
1 IC50 = 35 nM
CP0237916
(4R)-3-[2-[[1-[1-(3-chloro-4-fluorophenyl)imidazol-4-yl]cyclopropyl]amino]-5-fluoropyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H18ClF3N6O2
 1
1 IC50 = 35 nM
CP0440444
(4R)-3-[2-[[1-[1-(3,5-dichlorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H19Cl2FN6O2
 1
1 IC50 = 36 nM
CP0762757
(S)-2-(1-(6-chloro-7-fluoro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-4-methoxypyrimidine-5-carbonitrile
   Show/Hide
C17H13ClFN5O2
 2
1 IC50 = 36.5 nM
2 IC50 = 184 nM
CP0248665
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-(cyclohexylcarbamoyl)-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C33H32FN5O3
 1
1 IC50 = 37 nM
CP0366771
(4S)-3-(4-cyanopyrimidin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3,5-difluorophenyl)-2-oxo-1,3-oxazolidine-4-carboxamide
   Show/Hide
C29H22F4N6O4
 1
1 IC50 = 40 nM
CP0315104
(2S)-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-2-(3-fluoro-N-[2-[(2S)-1-(4-fluoropyridin-2-yl)-5-oxopyrrolidin-2-yl]acetyl]anilino)acetamide
   Show/Hide
C29H25ClF4N4O3
 1
1 IC50 = 40 nM
CP0243212
(4R)-3-[2-[[1-[1-(3-chloro-4-fluorophenyl)imidazol-4-yl]cyclobutyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C22H21ClF2N6O2
 1
1 IC50 = 40 nM
CP0714071
(S)-2-((1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-4-methylpyrimidine-5-carbonitrile
   Show/Hide
C17H14ClN5O
 2
1 IC50 = 40 nM
2 IC50 = 443 nM
CP0168841
(4R)-3-[2-[[1-[5-chloro-1-[3-(trifluoromethyl)phenyl]imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C22H19ClF4N6O2
 1
1 IC50 = 41 nM
CP0230166
(4S)-N-[(1S)-7-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-3-(4-cyanopyridin-2-yl)-N-(3-fluorophenyl)-2-oxo-1,3-oxazolidine-4-carboxamide
   Show/Hide
C30H23ClF3N5O4
 1
1 IC50 = 42 nM
CP0144333
(4R)-3-[2-[[1-[1-(3-chlorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H20ClFN6O2
 1
1 IC50 = 42 nM
CP0179104
methyl (2S)-2-[2-(N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-3-fluoroanilino)-2-oxoethyl]pyrrolidine-1-carboxylate
   Show/Hide
C26H27ClF3N3O4
 1
1 IC50 = 44 nM
CP0660539
(S)-5-((1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-6-methoxypicolinonitrile
   Show/Hide
C18H15ClN4O2
 2
1 IC50 = 44 nM
2 IC50 = 1015 nM
CP0210764
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3,5-difluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H25F4N5O3
 2
1 IC50 = 45 nM
2 IC50 = 3560 nM
CP0179105
(2S)-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-2-(3-fluoro-N-[2-[(2S)-5-oxo-1-pyrimidin-2-ylpyrrolidin-2-yl]acetyl]anilino)acetamide
   Show/Hide
C28H25ClF3N5O3
 1
1 IC50 = 45 nM
CP0368868
methyl N-[2-(N-[(1S)-2-(cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-3-fluoroanilino)-2-oxoethyl]carbamate
   Show/Hide
C25H30FN3O4
 1
1 IC50 = 46 nM
CP0101469
(2S)-N-[(1S)-5-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-1-(4-cyanopyridin-2-yl)-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H25ClF3N5O3
 2
1 IC50 = 49 nM
2 IC50 = 1780 nM
CP0069129
US10028961, Compound 121
   Show/Hide
C17H22F3N7
 1
1 IC50 < 50 nM
CP0179549
US10028961, Compound 128
   Show/Hide
C15H13F7N6S
 1
1 IC50 < 50 nM
CP0179571
US10028961, Compound 105
   Show/Hide
C20H22F6N6
 1
1 IC50 < 50 nM
CP0233887
US10028961, Compound 160
   Show/Hide
C20H22F7N7
 1
1 IC50 < 50 nM
CP0366769
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-7-fluoro-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H25F4N5O3
 1
1 IC50 = 51 nM
CP0541324
(2S)-N-[(1S)-4-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-1-(4-cyanopyridin-2-yl)-N-(3,5-difluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H24ClF4N5O3
 1
1 IC50 = 53 nM
CP0311207
(4S)-3-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3,5-difluorophenyl)-2-oxo-1,3-oxazolidine-4-carboxamide
   Show/Hide
C30H23F4N5O4
 1
1 IC50 = 54 nM
CP0563808
(4R)-3-[2-[[1-[1-(4-chlorophenyl)imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-4-[(1S)-1-fluoroethyl]-1,3-oxazolidin-2-one
   Show/Hide
C21H20ClFN6O2
 1
1 IC50 = 54 nM
CP0164420
(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[1-[5-methyl-1-[3-(trifluoromethyl)phenyl]imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C23H22F4N6O2
 1
1 IC50 = 56 nM
CP0311204
(4S)-3-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-2-oxo-1,3-oxazolidine-4-carboxamide
   Show/Hide
C30H24F3N5O4
 1
1 IC50 = 58 nM
CP0517962
(4S)-3-[2-[[(1S)-1-[5-(4-fluoro-3-methylphenyl)pyrazin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C23H25FN6O2
 1
1 IC50 = 62 nM
CP0164418
(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[1-[1-[4-(trifluoromethyl)phenyl]imidazol-4-yl]cyclopropyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C22H20F4N6O2
 1
1 IC50 = 65 nM
CP0541323
(2S)-N-[(1S)-4-chloro-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-1-(4-cyanopyridin-2-yl)-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H25ClF3N5O3
 1
1 IC50 = 67 nM
CP0239176
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-4-fluoro-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H25F4N5O3
 1
1 IC50 = 68 nM
CP0057375
N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C27H31FN4O2
 7
1 IC50 = 70 nM
2 IC50 = 160 nM
3 IC50 = 170 nM
4 IC50 = 200 nM
5 IC50 = 390 nM
6 IC50 > 20000 nM
7 IC50 > 100000 nM
CP0096016
(2S)-N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C27H31FN4O2
 1
1 IC50 = 70 nM
CP0165474
6-{[(6-chloro-2-oxo-1,2-
   Show/Hide
C17H13ClN4O
 3
1 IC50 = 72 nM
2 IC50 = 820 nM
3 IC50 = 75000 nM
CP0465226
(4R)-4-[(1R)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C23H22F4N6O2
 1
1 IC50 = 73 nM
CP0482623
(4S)-4-propan-2-yl-3-[2-[[(1S)-1-[5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C23H23F3N6O2
 1
1 IC50 = 77 nM
CP0349878
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(4,4-difluorocyclohexyl)methylcarbamoyl]-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C34H32F3N5O3
 1
1 IC50 = 80 nM
CP0269572
(4S)-3-[2-[[(1S)-1-[3-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C24H25F3N6O2
 1
1 IC50 = 84 nM
CP0346830
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(3-fluorophenyl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C31H26F3N5O3
 1
1 IC50 = 85 nM
CP0394027
5-[1-[[4-[(4R)-4-[(1S)-1-fluoroethyl]-2-oxo-1,3-oxazolidin-3-yl]pyrimidin-2-yl]amino]cyclopropyl]-3-[3-(trifluoromethyl)phenyl]imidazole-4-carbonitrile
   Show/Hide
C23H19F4N7O2
 1
1 IC50 = 85 nM
CP0101474
(2S)-1-(4-cyanopyridin-2-yl)-N-[(1S)-1-[(3,3-difluorocyclobutyl)carbamoyl]-2,3-dihydroinden-1-yl]-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
   Show/Hide
C30H25F3N6O3
 1
1 IC50 = 94 nM
CP0179496
rac-ML309
   Show/Hide
C29H29FN4O2
 1
1 IC50 < 100 nM
CP0764924
(5S)-4,4-dideuterio-5-isopropyl-1-[2-[[(1S)-1-[1-[4-(trifluoromethyl)phenyl]imidazol-4-yl]ethyl]amino]pyrimidin-4-yl]imidazolidin-2-one
   Show/Hide
C22H24F3N7O
 1
1 IC50 < 100 nM
CP0412483
(4S)-4-methyl-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
   Show/Hide
C22H21F3N6O2
 1
1 IC50 = 116 nM
CP0225556
4-{[(6-chloro-2-oxo-1,2-
   Show/Hide
C18H14ClN3O2
 3
1 IC50 = 127 nM
2 IC50 = 2250 nM
3 IC50 = 100000 nM
CP0239179
methyl N-[2-(N-[(1S)-1-(2-chlorophenyl)-2-(cyclohexylamino)-2-oxoethyl]-3-fluoroanilino)-2-oxoethyl]carbamate
   Show/Hide
C24H27ClFN3O4
 1
1 IC50 = 230 nM
CP0224971
CHEMBL4798388
   Show/Hide
C27H37N3O5
 3
1 IC50 = 270 nM
2 IC50 = 470 nM
3 IC50 > 50000 nM
CP0117942
(4S)-3-[2-[[(1S)-1-[5-(2-methylpyridin-4-yl)pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
   Show/Hide
C23H26N6O2
 1
1 IC50 = 339 nM
CP0564946
2-[(3S)-1-[5-[(5-hydroxy-2-adamantyl)carbamoyl]-6-(3-methylbutoxy)pyridin-2-yl]piperidin-3-yl]acetic acid
   Show/Hide
C28H41N3O5
 1
1 IC50 = 1300 nM
CP0070790
N-cyclohexyl-2-(3-fluoro-N-(2-thiophen-2-ylacetyl)anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C27H29FN2O2S
 1
1 IC50 = 2900 nM
CP0224960
2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-[(2-fluorophenyl)methoxy]pyridin-2-yl]piperidin-3-yl]acetic acid
   Show/Hide
C26H32FN3O4
 1
1 IC50 = 5600 nM
CP0070645
N-cyclohexyl-2-(3-fluoro-N-[2-(1H-indol-3-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C31H32FN3O2
 1
1 IC50 = 6300 nM
CP0070647
N-cyclopentyl-2-(3-fluoro-N-(2-thiophen-2-ylacetyl)anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C26H27FN2O2S
 1
1 IC50 = 7700 nM
CP0286878
N-cyclohexyl-2-(3-fluoro-N-(2-pyridin-4-ylacetyl)anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C28H30FN3O2
 1
1 IC50 = 19300 nM
CP0283017
N-cyclohexyl-2-(3-fluoro-N-[2-(1,3-thiazol-4-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C26H28FN3O2S
 1
1 IC50 = 19700 nM
CP0575184
2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-methoxypyridin-2-yl]piperidin-3-yl]acetic acid
   Show/Hide
C20H29N3O4
 1
1 IC50 > 50000 nM
CP0057374
N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylbenzimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C31H33FN4O2
 1
1 IC50 > 100000 nM
CP0176272
N-cyclohexyl-2-(3-fluoro-N-(2-indol-1-ylacetyl)anilino)-2-(2-methylphenyl)acetamide
   Show/Hide
C31H32FN3O2
 1
1 IC50 > 100000 nM
CP0423040
6-benzyl-1-hydroxy-4-methylpyridin-2-one
   Show/Hide
C13H13NO2
 1
1 Ki = 120 nM
Clinical Information about the Protein
Target 1 ( Oxalosuccinate decarboxylase (IDH1) )
Target Type Successful Target
Disease 3 Target-related Diseases  3
1 Advanced malignancy [ICD-11: 2A00-2F9Z]
2 Cholangiocarcinoma [ICD-11: 2C12.10]
3 Acute myeloid leukaemia [ICD-11: 2A60]
Approved Drug(s) 2 Approved Drugs  2
1 Ivosidenib Approved
Cholangiocarcinoma
2 Olutasidenib Approved
Acute myeloid leukaemia
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 IDH305 Phase 1
Advanced malignancy